What is compounding?
Drug compounding is often regarded as the process of combining or mixing drugs to create a medication tailored to the needs of an individual patient.
The generic form of Vetmedin is Pimobendan.
Vetmedin is in limited supply. Orders placed will be shipped as product continues to come off backorder.
GastroGard is the first and only medication approved by the FDA to treat Equine Gastric Ulcer Syndrome. GastroGard has been shown to safely and effectively treat existing stomach ulcers in horses and foals 4 weeks of age and older. It contains the active ingredient omeprazole which works to reduce stomach acid production at the source - the proton pump. With fewer active pumps, your horse's stomach produces sufficient acid to break down food, but not the excess acid that causes ulcers. By suppressing gastric acid production, GastroGard also helps prevent the recurrence of stomach ulcers.
GastroGard's active ingredient, omeprazole, is a gastric acid pump inhibitor that blocks the secretion of gastric acid regardless of the stimulus.
For treatment and prevention of recurrence of gastric ulcers in horses and foals 4 weeks of age and older.
For treatment of gastric ulcers, Gastrogard Paste should be administered orally once-a-day for 4 weeks at the recommended dosage of 1.8 mg omeprazole/lb body weight (4 mg/kg). For the prevention of recurrence of gastric ulcers, continue treatment for at least an additional 4 weeks by administering Gastrogard Paste at the recommended daily maintenance dose of 0.9 mg/lb (2 mg/kg).
Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian.
Do not use in horses intended for human consumption. Keep this and all drugs out of the reach of children. In case of ingestion, contact a physician. Physicians may contact a poison control center for advice concerning accidental ingestion.
In efficacy trials, when the drug was administered at 1.8 mg omeprazole/lb (4 mg/kg) body weight daily for 28 days and 0.9 mg omeprazole/lb (2 mg/kg) body weight daily for 30 additional days, no adverse reactions were observed.
The safety of Gastrogard Paste has not been determined in pregnant or lactating mares.
In a male reproductive safety study, 10 stallions received Gastrogard Paste at 12 mg/kg/day (3x the recommended dose) for 70 days. No treatment related adverse effects on semen quality or breeding behavior were observed. A safety study in breeding mares has not been conducted.
Store at 68°F - 77°F (20-25°C). Excursions between 59°F - 86°F (15-30°C) are permitted.